| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1050848579 |
| P356 | DOI | 10.1007/S00395-010-0121-4 |
| P8608 | Fatcat ID | release_ymgdr3jebvbsfbzbjptgobxxgu |
| P932 | PMC publication ID | 2965360 |
| P698 | PubMed publication ID | 20865418 |
| P5875 | ResearchGate publication ID | 46414683 |
| P50 | author | Gerd Heusch | Q29869951 |
| Hans Erik Bøtker | Q31229530 | ||
| Derek M. Yellon | Q33528795 | ||
| Gary F. Baxter | Q41880070 | ||
| Derek Hausenloy | Q42409890 | ||
| Rainer Schulz | Q47430697 | ||
| Sean M. Davidson | Q56988847 | ||
| John Malcolm Walker | Q68022597 | ||
| Masafumi Kitakaze | Q88336037 | ||
| Mihaela M Mocanu | Q90899693 | ||
| Sandrine Lecour | Q114429989 | ||
| Michel Ovize | Q114430026 | ||
| P2093 | author name string | Robert Bell | |
| Richard Shannon | |||
| Gail Walkinshaw | |||
| James Downey | |||
| Robert Mentzer | |||
| P2860 | cites work | Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial | Q33535020 |
| Infliximab attenuates early myocardial dysfunction after resuscitation in a swine cardiac arrest model | Q33753939 | ||
| Cyclosporine A at reperfusion reduces infarct size in pigs | Q33791098 | ||
| Myocardial reperfusion injury. | Q34687124 | ||
| Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial. | Q34935546 | ||
| Cardiac protection during acute myocardial infarction: where do we stand in 2004? | Q35840326 | ||
| Myocardial protection at a crossroads: the need for translation into clinical therapy | Q35844649 | ||
| Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs | Q35954778 | ||
| Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis | Q36515887 | ||
| Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. | Q37019662 | ||
| Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning. | Q37111331 | ||
| Remote ischaemic preconditioning: underlying mechanisms and clinical application. | Q37154560 | ||
| Limitation of myocardial infarct size in the clinical setting: current status and challenges in translating animal experiments into clinical therapy | Q37248348 | ||
| Preconditioning the diabetic human myocardium | Q37311040 | ||
| Loss of cardioprotection with ageing. | Q37379567 | ||
| Ischemic postconditioning: experimental models and protocol algorithms | Q37526561 | ||
| Coronary microembolization: from bedside to bench and back to bedside | Q37626321 | ||
| Cardiac preconditioning for ischaemia: lost in translation. | Q37675573 | ||
| Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology | Q37744271 | ||
| Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study | Q38501716 | ||
| Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes | Q39284051 | ||
| Aging mouse hearts are refractory to infarct size reduction with post-conditioning | Q39321486 | ||
| Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction | Q39868576 | ||
| Remote ischaemic preconditioning protects against cardiopulmonary bypass-induced tissue injury: a preclinical study | Q42831243 | ||
| Post-conditioning with cyclosporine A fails to reduce the infarct size in an in vivo porcine model | Q43067949 | ||
| Cyclosporine does not reduce myocardial infarct size in a porcine ischemia-reperfusion model | Q43076963 | ||
| Cyclosporine A administered during reperfusion fails to restore cardioprotection in prediabetic Zucker obese rats in vivo | Q43264111 | ||
| Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide | Q43653267 | ||
| Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury | Q43737906 | ||
| Quantification of myocardial area at risk with T2-weighted CMR: comparison with contrast-enhanced CMR and coronary angiography | Q43769708 | ||
| Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality | Q44244533 | ||
| Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion | Q44774818 | ||
| Cardiac troponin T elevation after coronary artery bypass grafting is associated with increased one-year mortality | Q45089770 | ||
| One hour reperfusion is enough to assess function and infarct size with TTC staining in Langendorff rat model. | Q45998298 | ||
| Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography. | Q46011772 | ||
| K(ATP) channel activation reduces the severity of postresuscitation myocardial dysfunction | Q46059291 | ||
| Ischemic postconditioning in pigs: no causal role for RISK activation. | Q46225223 | ||
| Effect of cyclosporine on reperfusion injury in acute myocardial infarction | Q46453592 | ||
| Mitochondrial permeability transition pore as a target for cardioprotection in the human heart | Q46551313 | ||
| Remote ischemic preconditioning of the recipient reduces myocardial ischemia-reperfusion injury of the denervated donor heart via a Katp channel-dependent mechanism | Q46562294 | ||
| Preconditioning the diabetic heart: the importance of Akt phosphorylation | Q46620654 | ||
| Postconditioning the human heart | Q46722557 | ||
| Long-term benefit of postconditioning | Q46758924 | ||
| Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials | Q46928598 | ||
| Systematic analysis of functional and structural changes after coronary microembolization: a cardiac magnetic resonance imaging study | Q48031201 | ||
| Thoracic Surgery Directors Association Award. Cobalt chloride pretreatment attenuates myocardial apoptosis after hypothermic circulatory arrest | Q48336927 | ||
| Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest | Q48356691 | ||
| Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial | Q48572279 | ||
| Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. | Q50647596 | ||
| Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning. | Q51093594 | ||
| Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction. | Q51093781 | ||
| Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. | Q51228456 | ||
| Adenosine A1 agonist at reperfusion trial (AART): results of a three-center, blinded, randomized, controlled experimental infarct study. | Q51360512 | ||
| Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. | Q51619864 | ||
| Cardioprotection by postconditioning is lost in WOKW rats with metabolic syndrome: role of glycogen synthase kinase 3beta. | Q54785513 | ||
| Early Metoprolol Administration Before Coronary Reperfusion Results in Increased Myocardial Salvage | Q56986728 | ||
| Preconditioning in isolated superfused human muscle | Q60343971 | ||
| Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects | Q67276951 | ||
| Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collabo | Q72665772 | ||
| The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion | Q73256108 | ||
| Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion | Q73265301 | ||
| Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery | Q79137159 | ||
| Cardioprotection: nitric oxide, protein kinases, and mitochondria | Q79780264 | ||
| Postconditioning protects human atrial muscle through the activation of the RISK pathway | Q80423743 | ||
| Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice | Q81514899 | ||
| Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection | Q82471465 | ||
| Neglect of the coronary circulation: some critical remarks on problems in the translation of cardioprotection | Q84105681 | ||
| Inhibition of mitochondrial permeability transition to prevent the post-cardiac arrest syndrome: a pre-clinical study | Q84133516 | ||
| P433 | issue | 6 | |
| P921 | main subject | workshop | Q27556165 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 677-686 | |
| P577 | publication date | 2010-09-24 | |
| P1433 | published in | Basic Research in Cardiology | Q2453360 |
| P1476 | title | Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations | |
| P478 | volume | 105 |
| Q36011190 | A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection. |
| Q37907329 | A role for GRK2 in myocardial ischemic injury: indicators of a potential future therapy and diagnostic |
| Q36694644 | Acute erythropoietin cardioprotection is mediated by endothelial response. |
| Q44261013 | Aging attenuates the protective effect of ischemic preconditioning against endothelial ischemia-reperfusion injury in humans. |
| Q48243115 | Aleglitazar, a Balanced Dual PPARα and -γ Agonist, Protects the Heart Against Ischemia-Reperfusion Injury |
| Q37638828 | Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia |
| Q47350464 | Aliskiren and Valsartan reduce myocardial AT1 receptor expression and limit myocardial infarct size in diabetic mice |
| Q44966048 | Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury |
| Q34091132 | Alterations in the interleukin-1/interleukin-1 receptor antagonist balance modulate cardiac remodeling following myocardial infarction in the mouse |
| Q47387978 | Apelin-13 limits infarct size and improves cardiac postischemic mechanical recovery only if given after ischemia. |
| Q37570347 | At the crossroads from bench to bedside: luteolin is a promising pharmacological agent against myocardial ischemia reperfusion injury |
| Q37973049 | Autophagy as a therapeutic target for ischaemia /reperfusion injury? Concepts, controversies, and challenges |
| Q35944872 | Blockade of electron transport at the onset of reperfusion decreases cardiac injury in aged hearts by protecting the inner mitochondrial membrane |
| Q35922588 | CTGF/CCN2 Postconditioning Increases Tolerance of Murine Hearts towards Ischemia-Reperfusion Injury |
| Q45247800 | Cardiac-derived adiponectin induced by long-term insulin treatment ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic mice via AMPK signaling |
| Q36420890 | Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion |
| Q37912844 | Cardioprotection by ivabradine through heart rate reduction and beyond. |
| Q36802290 | Cardioprotection by mild hypothermia during ischemia involves preservation of ERK activity |
| Q26866366 | Cardioprotection during cardiac surgery |
| Q35881667 | Cardioprotection of recombinant human MG53 protein in a porcine model of ischemia and reperfusion injury |
| Q54573276 | Class A scavenger receptor attenuates myocardial infarction-induced cardiomyocyte necrosis through suppressing M1 macrophage subset polarization. |
| Q37912861 | Clinical efforts to reduce myocardial infarct size--the next step |
| Q37140973 | Conditioning the heart to prevent myocardial reperfusion injury during PPCI |
| Q43999555 | Coronary microembolization during early reperfusion: infarct extension, but protection by ischaemic postconditioning |
| Q37895373 | Coronary no reflow |
| Q38872391 | Depressed Exercise Peak Ejection Rate Detected on Ambulatory Radionuclide Monitoring Reflects End-Stage Cardiac Inotropic Reserve and Predicts Mortality in Ischaemic Cardiomyopathy. |
| Q34004756 | Determination of the myocardial area at risk with pre- versus post-reperfusion imaging techniques in the pig model |
| Q47968505 | Diazoxide postconditioning induces mitochondrial protein S-nitrosylation and a redox-sensitive mitochondrial phosphorylation/translocation of RISK elements: no role for SAFE. |
| Q38194363 | Dipeptidyl peptidase IV inhibitors and ischemic myocardial injury |
| Q41892420 | Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion |
| Q49449899 | Does growth differentiation factor 11 protect against myocardial ischaemia/reperfusion injury? A hypothesis |
| Q45146419 | Does mild hypothermia protect against reperfusion injury? The debate continues |
| Q24289195 | ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies |
| Q38479165 | Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial. |
| Q46589926 | Effect of sulfur dioxide preconditioning on rat myocardial ischemia/reperfusion injury by inducing endoplasmic reticulum stress |
| Q64943661 | Effects of Cardiac Hypertrophy, Diabetes, Aging, and Pregnancy on the Cardioprotective Effects of Postconditioning in Male and Female Rats. |
| Q37871976 | Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum |
| Q35928926 | Endothelial-cardiomyocyte crosstalk enhances pharmacological cardioprotection |
| Q42861824 | Ethanolamine is a novel STAT-3 dependent cardioprotective agent |
| Q58447894 | Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction |
| Q54424234 | Exercise-induced cardioprotection is mediated by a bloodborne, transferable factor. |
| Q54568467 | Failure to recapture cardioprotection with high-dose atorvastatin in coronary artery bypass surgery: a randomised controlled trial. |
| Q28073354 | From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on "New frontiers in cardiovascular research" |
| Q40258000 | Gene transfer as a strategy to achieve permanent cardioprotection I: rAAV-mediated gene therapy with inducible nitric oxide synthase limits infarct size 1 year later without adverse functional consequences |
| Q84732981 | Genetic background, gender, age, body temperature, and arterial blood pH have a major impact on myocardial infarct size in the mouse and need to be carefully measured and/or taken into account: results of a comprehensive analysis of determinants of |
| Q36974257 | Genetic deletion of uncoupling protein 3 exaggerates apoptotic cell death in the ischemic heart leading to heart failure. |
| Q38061499 | Genetics and genomics of ischemic tolerance: focus on cardiac and cerebral ischemic preconditioning |
| Q54463866 | Glimepiride treatment facilitates ischemic preconditioning in the diabetic heart. |
| Q34215980 | HIF-1α signaling activation by post-ischemia treatment with astragaloside IV attenuates myocardial ischemia-reperfusion injury |
| Q35860938 | Hydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 Phosphorylation |
| Q47944673 | Impact of lifelong exercise training on endothelial ischemia-reperfusion and ischemic preconditioning in humans |
| Q36355264 | Influence of tumour necrosis factor alpha on the outcome of ischaemic postconditioning in the presence of obesity and diabetes |
| Q54513464 | Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo. |
| Q92593739 | Investigation of the underlying hub genes and mechanisms of reperfusion injury in patients undergoing coronary artery bypass graft surgery by integrated bioinformatic analyses |
| Q38722304 | Ischaemic conditioning and reperfusion injury. |
| Q38427068 | Ischaemic conditioning: are we there yet? |
| Q35631620 | Ischemic preconditioning: the role of mitochondria and aging |
| Q87074288 | Mediation of dopamine D2 receptors activation in post-conditioning-attenuated cardiomyocyte apoptosis |
| Q36371672 | Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia: between bench and bedside |
| Q44188620 | Melatonin, given at the time of reperfusion, prevents ventricular arrhythmias in isolated hearts from fructose-fed rats and spontaneously hypertensive rats. |
| Q46736926 | MicroRNA-155 aggravates ischemia-reperfusion injury by modulation of inflammatory cell recruitment and the respiratory oxidative burst |
| Q60056507 | Microvesicles and Exosomes in Local and Distant Communication with the Heart |
| Q54621218 | Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction. |
| Q28543466 | Myocardial creatine levels do not influence response to acute oxidative stress in isolated perfused heart |
| Q36497176 | Myocardial ischemia-reperfusion injury: a neglected therapeutic target. |
| Q41703806 | Necrostatin-1 alleviates reperfusion injury following acute myocardial infarction in pigs. |
| Q37007953 | New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop |
| Q35016000 | New technique of local ischemic preconditioning induction without repetitive aortic cross-clamping in cardiac surgery. |
| Q46402883 | Notch1 cardioprotection in myocardial ischemia/reperfusion involves reduction of oxidative/nitrative stress |
| Q47178073 | Novel Synthesized Radical-Containing Nanoparticles Limit Infarct Size Following Ischemia and Reperfusion in Canine Hearts |
| Q39739258 | Optimal timing of hypothermia in relation to myocardial reperfusion |
| Q51317623 | PTEN upregulation may explain the development of insulin resistance and type 2 diabetes with high dose statins. |
| Q47388835 | Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner |
| Q37988319 | Pleiotropic effects of dronedarone on ischemia/reperfusion injury in heart and brain. |
| Q47620961 | Postconditioning with glucagon like peptide-2 reduces ischemia/reperfusion injury in isolated rat hearts: role of survival kinases and mitochondrial KATP channels |
| Q53083983 | Preclinical studies of human disease: time to take methodological quality seriously. |
| Q48212106 | Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial |
| Q35893836 | Protective Effect of Creatine Elevation against Ischaemia Reperfusion Injury Is Retained in the Presence of Co-Morbidities and during Cardioplegia |
| Q54520877 | Protective effect of ischemic postconditioning against ischemia reperfusion-induced myocardium oxidative injury in IR rats. |
| Q42749210 | Reduction of myocardial infarct size by dronedarone in pigs--a pleiotropic action? |
| Q48266257 | Remote intermittent ischemia before coronary artery bypass graft surgery: a strategy to reduce injury and inflammation? |
| Q38639332 | Remote ischaemic conditioning-a new paradigm of self-protection in the brain. |
| Q43758053 | Remote ischaemic postconditioning: does it protect against ischaemic damage in percutaneous coronary revascularisation? Randomised placebo-controlled clinical trial |
| Q34458416 | Remote ischemic conditioning. |
| Q37912853 | Remote ischemic conditioning: a clinical trial's update |
| Q26828968 | Remote ischemic conditioning: from experimental observation to clinical application: report from the 8th Biennial Hatter Cardiovascular Institute Workshop |
| Q36680922 | Remote ischemic preconditioning confers late protection against myocardial ischemia-reperfusion injury in mice by upregulating interleukin-10. |
| Q50863981 | Right ventricular hypertrophy and failure abolish cardioprotection by ischaemic pre-conditioning. |
| Q35864123 | Role of Mitogen-Activated Protein Kinases in Myocardial Ischemia-Reperfusion Injury during Heart Transplantation |
| Q42293459 | Role of carbonyl sulfide in acute lung injury following limb ischemia/reperfusion in rats |
| Q38573070 | Statin-Induced Cardioprotection Against Ischemia-Reperfusion Injury: Potential Drug-Drug Interactions. Lesson to be Learnt by Translating Results from Animal Models to the Clinical Settings |
| Q26825240 | Stenting technique, gender, and age are associated with cardioprotection by ischaemic postconditioning in primary coronary intervention: a systematic review of 10 randomized trials |
| Q38202410 | Stromal derived factor 1α: a chemokine that delivers a two-pronged defence of the myocardium. |
| Q47348822 | Supplemental oxygen in patients without hypoxia in ST segment elevation myocardial infarction increases myocardial injury and infarct size |
| Q38010782 | Targeting reperfusion injury in acute myocardial infarction: a review of reperfusion injury pharmacotherapy |
| Q37738596 | Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations. |
| Q37375425 | The ERK1/2 signaling pathway is involved in sulfur dioxide preconditioning-induced protection against cardiac dysfunction in isolated perfused rat heart subjected to myocardial ischemia/reperfusion |
| Q54429906 | The GTN patch: a simple and effective new approach to cardioprotection? |
| Q53287714 | The PI3K/Akt, p38MAPK, and JAK2/STAT3 signaling pathways mediate the protection of SO2 against acute lung injury induced by limb ischemia/reperfusion in rats. |
| Q51124858 | The RIPOST-MI study, assessing remote ischemic perconditioning alone or in combination with local ischemic postconditioning in ST-segment elevation myocardial infarction. |
| Q36031657 | The alpha1 isoform of soluble guanylate cyclase regulates cardiac contractility but is not required for ischemic preconditioning |
| Q47255415 | The antiarrhythmic dipeptide ZP1609 (danegaptide) when given at reperfusion reduces myocardial infarct size in pigs |
| Q37850517 | The in-situ pig heart with regional ischemia/reperfusion - ready for translation. |
| Q54497300 | The mechanism of beta-adrenergic preconditioning: roles for adenosine and ROS during triggering and mediation. |
| Q38274962 | The mitochondrial permeability transition pore and its role in myocardial ischemia reperfusion injury. |
| Q37926558 | The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury |
| Q37892335 | The therapeutic potential of ischemic conditioning: an update |
| Q35043452 | Therapeutic potential of intermittent hypoxia: a matter of dose |
| Q38318626 | Trans-system mechanisms against ischemic myocardial injury |
| Q38075417 | Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. |
| Q38612855 | Translational failure of anti-inflammatory compounds for myocardial infarction: a meta-analysis of large animal models |
| Q38026951 | Volatile anaesthetics and cardioprotection: lessons from animal studies. |
| Q38108537 | What is the role of erythropoietin in acute myocardial infarct? Bridging the gap between experimental models and clinical trials |
| Q54343158 | β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes. |
Search more.